Extracellular serine protease
View Patent ↗The present invention provides a DNA encoding a novel extracellular serine protease termed Tumor Antigen Derived Gene-14 (TADG-14) which is overexpressed in ovarian, breast and colon carcinoma samples. Also provided are vector and host cells capable of expressing the DNA of the present invention, as well as the uses of the DNA and protein of the present invention. Also provided is a TADG-14 protein variant that has a potential role for detecting and targeting of ovarian carcinomas.
1. An isolated DNA that differs from the nucleic acid sequence of SEQ ID NO: 6 due to inclusion of an intron sequence between exon 2 and exon 3 of SEQ ID NO: 6, said DNA encoding a TADG-14 protein variant with an amino acid sequence shown in SEQ ID NO: 75.
2. A vector capable of expressing the DNA of claim 1 , wherein said vector is adapted for expression in a cell and comprises regulatory elements necessary for expressing said DNA in said cell.
3. A host cell transfected with the vector of claim 2 , wherein said vector expresses a TADG-14 protein variant with the amino acid sequence shown in SEQ ID NO: 75.
4. The host cell of claim 3 , wherein said cell is a bacterial cell, a mammalian cell, a plant cell or an insect cell.